Dewpoint Therapeutics Awarded Target ALS Grant for Development of C-mods for ALS
BOSTON, Massachusetts, January 11, 2024 – Dewpoint Therapeutics Inc., a biotechnology company that translates the novel science of condensates into breakthrough therapeutics, today […]